DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2232051/aes-aes-q4-earnings-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232051 Feb 26, 2024 - AES (AES) delivered earnings and revenue surprises of 5.80% and 4.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2232038/sterling-infrastructure-strl-tops-q4-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232038 Feb 26, 2024 - Sterling Infrastructure (STRL) delivered earnings and revenue surprises of 30% and 7.77%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2232028/everquote-ever-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232028 Feb 26, 2024 - EverQuote (EVER) delivered earnings and revenue surprises of 38.71% and 11.66%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2232011/heico-corporation-hei-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232011 Feb 26, 2024 - Heico Corporation (HEI) delivered earnings and revenue surprises of 12.33% and 2.40%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2231988/theravance-biopharma-tbph-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231988 Feb 26, 2024 - Theravance Bio (TBPH) delivered earnings and revenue surprises of 175% and 0.43%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2231982/trex-trex-q4-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231982 Feb 26, 2024 - Trex (TREX) delivered earnings and revenue surprises of 5.26% and 1.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2231983/fate-therapeutics-fate-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231983 Feb 26, 2024 - Fate Therapeutics (FATE) delivered earnings and revenue surprises of 21.05% and 97.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2231985/workday-wday-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2231985 Feb 26, 2024 - Workday (WDAY) delivered earnings and revenue surprises of 9.03% and 0.45%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/commentary/2231979/3-top-ranked-tech-stocks-flexing-solid-growth?cid=CS-ZC-FT-investment_ideas-2231979 Feb 26, 2024 - While many headlines have been centered around the 'Mag 7', there are plenty of other technology stocks currently carrying bright outlooks, including these three. 0

https://www.zacks.com/stock/news/2231976/top-stock-picks-for-the-week-of-february-26-2024?cid=CS-ZC-FT-video_blog-2231976 Feb 26, 2024 - A Top-Ranked Materials Firm That Posted Blowout Results and the Giant of AI Chips... 0